Sue Gail Eckhardt - Net Worth and Insider Trading

Sue Gail Eckhardt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sue Gail Eckhardt owns 1 companies in total, including Syros Pharmaceuticals Inc (SYRS) .

Click here to see the complete history of Sue Gail Eckhardt’s form 4 insider trades.

Insider Ownership Summary of Sue Gail Eckhardt

Ticker Comapny Transaction Date Type of Owner
SYRS Syros Pharmaceuticals Inc 2020-09-08 director

Sue Gail Eckhardt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sue Gail Eckhardt Ownership Network

Ownership Network List of Sue Gail Eckhardt

No Data

Ownership Network Relation of Sue Gail Eckhardt

Insider Network Chart

Sue Gail Eckhardt Owned Company Details

What does Syros Pharmaceuticals Inc do?

Who are the key executives at Syros Pharmaceuticals Inc?

Sue Gail Eckhardt is the director of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .

Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary

Over the past 18 months, Sue Gail Eckhardt made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Chee Conley .

In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Syros Pharmaceuticals Inc Insider Transactions

No Available Data

Sue Gail Eckhardt Mailing Address

Above is the net worth, insider trading, and ownership report for Sue Gail Eckhardt. You might contact Sue Gail Eckhardt via mailing address: C/o Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge Ma 02140.